AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2020
Nov 4, 2020
32407_dirs_2020-11-03_8d03ef37-a93a-4b7f-a2ed-b623afcb37ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2020-11-02
Reporting Person: Nabulsi Azmi (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-25 | Common Stock | G | 867200 | $0.00 | Disposed | 0 | Direct |
| 2020-06-25 | Common Stock | G | 867200 | $0.00 | Acquired | 867200 | Indirect |
| 2020-11-02 | Common Stock | S | 14500 | $36.8294 | Disposed | 852700 | Indirect |
Footnotes
F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12